|
Market Closed -
Bombay S.E.
13:02:27 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,271.50 INR | +2.22% |
|
+0.42% | +23.37% |
| 09-25 | Caplin Point Laboratories Limited Approves Appointment of D Muralidharan as Whole Time Director | CI |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAPLIN POINT LABORATORIES LIMITED | Generic Pharmaceuticals | +2.22% | +0.42% | +23.37% | +13.50% | +162.72% | 1.78B |  |  | |
Select your edition
All financial news and data tailored to specific country editions
